SCHEMBL5203381

SCHEMBL5203381

CCCCCC(CCCO)CC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.55
LMNA P02545 3/20 0.48
FFAR1 O14842 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
PPARD Q03181 2/20 0.42
MAPT P10636 1/20 0.42
LCK P06239 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AKR1B1 P15121 1/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,6-Hexanediol SCHEMBL5137760 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137115 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137134 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
1,6-Hexanediol SCHEMBL5137145 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL7202803 0.94 GPR84 (0.58) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL3930995 0.94 GPR84 (0.47) GPR84LMNAFFAR1FFAR4SMN1; SMN2
SCHEMBL5137823 0.93 LMNA (0.57) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL5136356 0.93 LMNA (0.57) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL5137665 0.93 LMNA (0.57) GPR84LMNAFFAR1FFAR4PPARD
SCHEMBL5137344 0.93 LMNA (0.57) GPR84LMNAFFAR1FFAR4PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150996-B1 NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRAZENECA AB (SE) 2007-11-21 EP disclosed
US-6599894-B1 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants AstŕaZeneca AB (SE) 2003-07-29 US disclosed